Advertisement
Advertisement

EXEL

EXEL logo

Exelixis Inc

41.34
USD
Sponsored
-0.94
-2.21%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

41.35

+0.01
+0.02%

EXEL Earnings Reports

Positive Surprise Ratio

EXEL beat 32 of 40 last estimates.

80%

Next Report

Date of Next Report
Feb 10, 2026
Estimate for Q4 25 (Revenue/ EPS)
$617.32M
/
$0.77
Implied change from Q3 25 (Revenue/ EPS)
+3.27%
/
+11.59%
Implied change from Q4 24 (Revenue/ EPS)
+8.92%
/
+60.42%

Exelixis Inc earnings per share and revenue

On Nov 04, 2025, EXEL reported earnings of 0.69 USD per share (EPS) for Q3 25, beating the estimate of 0.63 USD, resulting in a 9.28% surprise. Revenue reached 597.75 million, compared to an expected 602.11 million, with a -0.72% difference. The market reacted with a +6.52% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 23 analysts forecast an EPS of 0.77 USD, with revenue projected to reach 617.32 million USD, implying an increase of 11.59% EPS, and increase of 3.27% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Exelixis Inc reported EPS of $0.69, beating estimates by 9.28%, and revenue of $597.75M, -0.72% below expectations.
The stock price moved up 6.52%, changed from $37.90 before the earnings release to $40.37 the day after.
The next earning report is scheduled for Feb 10, 2026.
Based on 23 analysts, Exelixis Inc is expected to report EPS of $0.77 and revenue of $617.32M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement